Koh Y Y, Park Y, Kim C K
Department of Pediatrics and Clinical Research Institute, Seoul National University Hospital, Seoul, Korea.
Allergy. 2002 Dec;57(12):1165-70. doi: 10.1034/j.1398-9995.2002.23602.x.
A significant proportion of patients diagnosed with cough-variant asthma eventually manifest classic asthma signs, such as wheezing and dyspnea. The aim of this study was to investigate whether the degree of airway hypersensitivity and/or the level of maximal airway response can predict the development of wheezing in subjects with cough-variant asthma.
At study initiation, a high-dose methacholine inhalation test was performed to measure provocative concentration causing a 20% fall (PC20) in forced expiratory volume in 1 s (FEV1) and maximal airway response. Each person was evaluated regularly every 3 months for 4 years and also on the occasion of wheezing being perceived for the first time.
Of the 48 patients available in the follow-up period, 21 (Group 1) developed clinical wheezing, while 27 (Group 2) did not. There was no significant difference in PC20 levels between the two groups. The level of maximal airway response, however, was significantly higher in Group 1 than in Group 2. The score test for trend revealed a significant association between the future development of wheezing and the level of maximal airway response (P = 0.007), but not the level of methacholine PC20 (P = 0.423).
The level of maximal airway response, rather than the degree of airway hypersensitivity, may be an important risk factor for the future development of classic asthma in patients with cough-variant asthma.
相当一部分被诊断为咳嗽变异性哮喘的患者最终会出现典型的哮喘症状,如喘息和呼吸困难。本研究的目的是调查气道高反应性程度和/或最大气道反应水平是否能够预测咳嗽变异性哮喘患者喘息的发生。
在研究开始时,进行高剂量乙酰甲胆碱吸入试验,以测量使一秒用力呼气容积(FEV1)下降20%的激发浓度(PC20)和最大气道反应。对每个人每3个月定期评估一次,持续4年,并且在首次感觉到喘息时也进行评估。
在随访期内的48例患者中,21例(第1组)出现了临床喘息,而27例(第2组)未出现。两组之间的PC20水平没有显著差异。然而,第1组的最大气道反应水平显著高于第2组。趋势评分检验显示,喘息的未来发展与最大气道反应水平之间存在显著关联(P = 0.007),但与乙酰甲胆碱PC20水平无关(P = 0.423)。
对于咳嗽变异性哮喘患者,最大气道反应水平而非气道高反应性程度可能是未来发生典型哮喘的重要危险因素。